InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...
Ethiopia is taking significant steps to address the rising prevalence rate of diabetes, a condition that poses a growing public health challenge in the country. Following the increasing prevalence of ...